Showing results (11-20 of 504) with videos related to
Sort By:
Pageof 51
Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 1998
Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-IR Batal, M Tremblay, L Krimbou, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1996
Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjectsJ S Cohn, M Tremblay, M Amiot, et al.Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|August 1, 1994
Response to HMG CoA reductase inhibitors in heterozygous familial hypercholesterolemia due to the 10-kb deletion ("French Canadian mutation") of the LDL receptor geneL Karayan, S Qiu, C Betard, et al.The Canadian Journal of Cardiology|March 1, 1997
Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French CanadiansM Weber, S McNicoll, M Marcil, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|April 1, 1987
[The predictive value of apolipoproteins in atheroma]J DavignonAdvances in Experimental Medicine and Biology|March 20, 2002
Advances in lipid-lowering therapy in atherosclerosisJ DavignonThe Canadian Journal of Cardiology|October 1, 1996
A lipid clinic associated with a research laboratory working on dyslipoproteinemias and atherosclerosisJ DavignonEvidence-Based Cardiovascular Medicine|June 1, 1997
Lipid lowering in patients with coronary artery disease: low density lipoprotein cholesterol and beyondJ DavignonEuropean Journal of Clinical Pharmacology|January 1, 1991
Indications for lipid-lowering drugsJ DavignonPageof 51